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Abstract
Clinical Vignette: A 67-year-old female with advanced Parkinson’s disease (PD), medically refractory tremor, and a history of significant depression presented for
evaluation of deep brain stimulation (DBS) candidacy.
Clinical Dilemma: Traditionally, the subthalamic nucleus (STN) has been preferred over the globus pallidus interna (GPi) as a DBS target for PD patients with
levodopa-responsive fluctuations in rigidity and akinesia, for whom tremor is also a significant source of impairment. However, STN stimulation is avoided in
patients with a significant pre-surgical history of mood disorder.
Clinical Solution: Bilateral DBS of the GPi led to significant short-term improvement in PD motor symptoms, including significant tremor reduction.
Gap in Knowledge: There is insufficient evidence to support or refute clinicians’ traditional preference for STN stimulation in treating refractory PD tremor.
Similarly, the available evidence for risk of worsening depression and/or suicidality after STN DBS is mixed. Both questions require further clarification to guide
patient and clinician decision-making.
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Clinical Vignette
A 67-year-old right-handed female presented for evaluation of deep
brain stimulation (DBS) surgery candidacy for advanced Parkinson’s
disease (PD). She had developed PD 18 years prior to evaluation, with
rest tremor of the left hand. Her symptoms progressed to include
severe bilateral tremor with mild rigidity, bradykinesia, and shuffling
gait. She had a robust levodopa response that waned over time, such
that each dose of carbidopa–levodopa gave her approximately 2 hours
of medication-on time. Her tremor remained significant in spite of
medication and interfered with daily activities such as cooking, using
utensils, and holding cups. Her medications included carbidopa–levodopa,
amantadine, rotigotine, and pramipexole (levodopa daily dose equivalent
920mg). Her history was complicated by depression with two prior
episodes of possible suicide attempt. In both instances, she felt her
actions were related to erratic behavior caused by her medications.
The last episode occurred 5 years prior to her evaluation. She saw
a therapist regularly and did not require pharmacologic treatment
for depression. She had a remote history of discrete episodes of hal-
lucinations, related to medication effect or concurrent urinary tract
infection. Movement Disorder Society Unified Parkinson’s Disease
Rating Scale (MDS-UPDRS) in the off-medication state was 54. This
improved to 28 in the on-medication state. Neuropsychological test-
ing revealed robust abilities across all cognitive domains, including
attention, processing speed, language, visuospatial abilities, memory
and executive functioning. Testing did reveal a concern for her history
of suicide attempt and her insight into its causes.
Clinical Dilemma
Correct target selection for DBS in PD is a critical step in delivering
efficacious treatment. Although stimulation of the ventral intermediate
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(Vim) nucleus of the thalamus can address unilateral tremor in PD,
it does not impact rigidity, akinesia, or levodopa-induced dyskinesia
meaningfully.1,2 Bilateral Vim stimulation also raises concern for exacer-
bating speech impairment and gait imbalance.3 To address the totality of
motor fluctuations in advanced PD with DBS, clinicians have favored
the implantation of the globus pallidus interna (GPi) and subthalamic
nucleus (STN), although at varying rates over time. Traditionally, of
these two targets, the STN is thought to provide greater tremor control.4
Indeed, STN stimulation was shown to be equivalent to Vim stimulation
for PD tremor in a small series of patients with significant rest and action
tremor.5 However, STN stimulation has also been associated with a
concern for worsening depression and higher rates of suicide attempt.6
The patient under discussion suffered from significant resting and
postural tremor, and has a concerning history of depression and suicide
attempt, making the ideal surgical target unclear based on these perhaps
dogmatic views. Should Vim be selected at the risk of leaving akinesia
and rigidity unaddressed? If the STN is targeted, will the patient be
exposed to an unacceptable increased risk of suicidality or depression in
the name of tremor reduction? If GPi is selected to avoid possible
worsening of mood disorder with STN stimulation, can the patient be
assured that her significant tremor will respond to DBS?
Clinical Solution
The patient was discussed extensively within the multidisciplinary
DBS team, consisting of a movement disorders neurologist, functional
neurosurgeon, and neuropsychologist. Her therapist provided support-
ing information regarding the stability of her depression. The patient
was counseled extensively regarding the risks and benefits of DBS,
and the concerns of exacerbating neuropsychiatric deficits with STN
stimulation, or failing to address non-tremor symptoms with Vim stimu-
lation. A decision was made to offer the patient magnetic resonance
imaging-guided bilateral GPi DBS. She underwent surgery without
complication. Initial programming showed an improvement in her
MDS-UPDRSIII of 55% in the on-stimulation/off-medication state
compared with her off-stimulation/off-medication state (MDS-UPDRSIII
scores of 24 and 53, respectively), with significant improvement in
tremor severity and constancy (Video 1). Long-term follow-up is not
yet available.
Gap in Knowledge
The debate over the merits of GPi and STN stimulation in PD
have been extensively catalogued. Ultimately, the collective body of
evidence suggests that the two targets are similar in their motor
benefits, but STN may be superior to GPi in regards to economic
profile (fewer battery replacements) and medication reduction; GPi is
superior to STN in regards to dyskinesia control and medication
flexibility.7 These considerations were not the most pressing sources of
debility or risk for the patient under discussion. Informal discussions
with DBS clinicians would suggest that of these two targets, STN
treatment remains the preferred choice for PD patients in need of
significant tremor control, and a target to avoid in patients with
significant comorbid psychiatric illness. What evidence supports these
biases?
There are limited reports on the effect of GPi stimulation in cases of
severe PD tremor or benign tremulous PD. A review of cases of
rigorously defined benign tremulous PD implanted at the Mayo Clinic
over a 14-year period showed no cases of GPi implantation (15 patients
with Vim and STN stimulation were identified).8 This likely reflects a
target selection bias stemming from the historical use of Vim stimu-
lation for tremor, and STN stimulation for PD tremor. This is in spite
of evidence of improvement in severe tremor in patients undergoing
pallidotomy.9 Retrospective reviews provide some support for GPi and
STN target equivalency in tremor reduction. Katz et al.10 reviewed the
Veterans Administration (VA) Cooperative Studies Program #468 by
analyzing the response of different PD motor subtypes to GPi and
STN stimulation. They analyzed tremor dominant (TD), postural
instability gait difficulty, and intermediate subtypes. TD subtype was
determined by a cumulative UPDRS tremor subscale score 1.5 times
greater than that of the subscale items for balance and gait. TD
patients experienced greater mean overall improvement, as measured
by the UPDRSIII, after GPi DBS than after STN DBS. However, the
discrepancy in improvement was mainly accounted for by improve-
ment in gait. Tremor subscales showed no significant difference in
improvement based on target.10
A few prospective randomized trials have attempted to compare GPi
and STN stimulation directly. A single-center study of 23 patients
randomized to GPi and STN stimulation, with blinded assessment
after 1 year, found UPDRS tremor subscores in either group showed
no statistical difference.11 Larger, more recent studies have shown a
similar equivalency in tremor reduction. The aforementioned VA
study found that stimulation at either target provided similar overall
motor benefits.12 However, no analysis of tremor subscale was pro-
vided in the initial reports of outcomes at 6 and 24 months after DBS.
A subset of these patients was followed at 36 months and showed
similar overall UPDRSIII improvement, while specifically reporting
Video 1. Rest tremor prior to and immediately after initial
programming of bilateral globus pallidus interna (GPi) deep brain
stimulation. Left GPi settings were (c+,2–) at 2 volts, pulse width 90 ms, and
frequency 180 Hz. Therapy current was 1.883 mA. Right GPi settings were
(c+,10–) at 2 volts, pulse width 90 ms, and frequency 180 Hz. The therapy
current was 2.677 mA.
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tremor subscale scores which showed equal improvement between
STN and GPi groups.13
Other large prospective randomized trials provide conflicting evi-
dence regarding target equivalency for improving PD motor symp-
toms. The COMPARE trial analyzed cognition and mood changes
between STN and GPi stimulation as its primary outcome, but in
secondary analysis UPDRS motor scores showed no significant differ-
ence between groups.14 The NSTAPS study, did find a greater mean
improvement in the secondary outcome measure of UPDRSIII motor
scores in the off-medication state after STN DBS than GPi.15 How-
ever, neither prospective study commented on GPi and STN benefit
for tremor specifically. When the evidence of clinical outcomes is
reviewed, clinicians’ preference in treating severe PD tremor with STN
DBS has little support.
Perhaps tremor should not be regarded as a guiding feature of target
selection as our clinical dilemma suggests. What then of our perception
of the adverse psychiatric effects of STN stimulation? In a large,
multicenter survey of patients with STN DBS, Voon et al.6 found that
the risk of suicide in the first postoperative year is elevated. Attempted
suicides were associated with postoperative depression, being single,
and a prior history of suicide attempt and impulse control disorder.6
The association of STN stimulation and increased suicide risk is
controversial. A careful analysis of the VA cooperative study found no
increased risk of suicidal ideation postoperatively, nor between STN
and GPi groups.16
Postoperative depression, as a risk factor for suicidality, has also
been evaluated with mixed results. The VA cooperative study did
suggest a small but statistically significant worsening of depressive
symptoms 2 years after STN DBS, but those with GPi DBS showed
slight improvement.12 The aforementioned COMPARE trial found no
difference in visual analog mood subscales between GPi and STN
groups.14 Two retrospective studies investigated whether a history of
preoperative depression was more likely to lead to postoperative
depression. A 2002 retrospective review of 24 STN DBS patients, 12 of
whom had depressive episodes prior to surgery, found five patients
with a persistent depressive episode postoperatively, in spite of sig-
nificant motor benefit.17 Four of these patients were among those with
presurgical depression. A larger retrospective review of 110 patients
with DBS, to either the STN or GPi, showed that those with a his-
tory of presurgical depression had higher postsurgical Beck Depres-
sion Inventory scores than those without a history of depression.18 The
study was not designed to detect a difference between the surgical
targets.
Additionally, aggressive medication reduction in the postoperative
period appears to be related to the incidence of apathy and depression,
suggesting that if there is a correlation between STN DBS and
worsening depression, it may be a result of aggressive medication
reduction and not the stimulation per se.19 Indeed, four out of five of
the patients in the 2002 review of STN DBS who experienced
postoperative depression were noted to have had a .60% reduction
(and in one case complete withdrawal) of their levodopa.17 Other
studies have shown an improvement in depressive symptoms in the
first 6 months after STN DBS, suggesting that effective stimulation and
careful postoperative medication management should not be expected
to have negative consequences on mood.20
In conclusion, further research is needed to provide evidence-based
guidelines for target selection for DBS in advanced PD. The available
evidence suggests that STN and GPi DBS are equivalent for PD
tremor reduction. Clinicians’ bias towards STN targeting for tremor
reduction either fails to recognize that equivalency, or represents a
practical experience that has failed to be recognized in the literature.
Similarly, a more definitive understanding of the effects of stimulation
targets on depression and suicidality would offer clinicians and patients
a more accurate assessment of possible psychiatric risk when deciding
to proceed with an elective invasive surgery.
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